Matches in Nanopublications for { ?s ?p "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP83409.RALmUTS7ehHC8TE4f67fUYkktQJAEVY67-KR6BBzodAcM130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83409.RALmUTS7ehHC8TE4f67fUYkktQJAEVY67-KR6BBzodAcM130_provenance.
- NP87620.RARVo2NBGai5byuzGb_1Wsud1P-BbRWhDO0xqp6KYesIo130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87620.RARVo2NBGai5byuzGb_1Wsud1P-BbRWhDO0xqp6KYesIo130_provenance.
- NP83415.RAf82m85OWZCRVLUVnZ1jU8l4Y6LFMbdJOxZSYwnOpb9Q130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83415.RAf82m85OWZCRVLUVnZ1jU8l4Y6LFMbdJOxZSYwnOpb9Q130_provenance.
- NP67851.RA2sFKLQ5TciPuXTwxJJ-zJcAAGPDkKU9juDMPM3dT3ao130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67851.RA2sFKLQ5TciPuXTwxJJ-zJcAAGPDkKU9juDMPM3dT3ao130_provenance.
- assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP173269.RAQgfDUOL9CDuEUGujbfd_VqEIOQ6VlMqEvTKCxfQH2No130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173269.RAQgfDUOL9CDuEUGujbfd_VqEIOQ6VlMqEvTKCxfQH2No130_provenance.
- NP87804.RAIMHaZKQVEPuYxuga9uvc4BDg9tXq3RVhih7HoCFkBhY130_assertion description "[The E17K substitution in AKT1 is rare in prostate cancer. It seems associated with a favourable clinical outcome but not with a specific histology of the tumour.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87804.RAIMHaZKQVEPuYxuga9uvc4BDg9tXq3RVhih7HoCFkBhY130_provenance.